Paper39409154
The Versatile Roles of nc886, a Fascinating and Peculiar Regulatory Non-Coding RNA, in Cancer.
Jang JJ and 3 others. Int J Mol Sci, 2024. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. The Versatile Roles of nc886, a Fascinating and Peculiar Regulatory Non-Coding RNA, in Cancer. Papers, record 39409154. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39409154
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The Versatile Roles of nc886, a Fascinating and Peculiar Regulatory Non-Coding RNA, in Cancer.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Gene Expression Regulation, Neoplastic | Major topic |
| Neoplasms | Major topic |
| RNA, Untranslated | Major topic |
| Animals | |
| Humans | |
| Carcinogenesis | |
| DNA Methylation | |
| Promoter Regions, Genetic | |
| Ribonuclease III | |
| eIF-2 Kinase | |
| MicroRNAs |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| NCC- 2311362 | National Cancer Center, Korea | PubMed | ||
| NCC- 24H1260 | National Cancer Center, Korea | PubMed | ||
| NCC- 2411900 | National Cancer Center, Korea | PubMed |
Source PubMed
References64
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 3028245 | The myc oncogene: its role in transformation and differentiation. | Annu Rev Genet | 1986 | https://conductscience.org/library/papers/3028245 | PubMed |
| 2 | 10557102 | PKR; a sentinel kinase for cellular stress. | Oncogene | 1999 | https://conductscience.org/library/papers/10557102 | PubMed |
| 3 | 29394925 | Nc886 is epigenetically repressed in prostate cancer and acts as a tumor suppressor through the inhibition of cell growth. | BMC Cancer | 2018 | https://conductscience.org/library/papers/29394925 | PubMed |
| 4 | 26846681 | Aberrantly methylated DNA regions lead to low activation of CD4+ T-cells in IgA nephropathy. | Clin Sci (Lond) | 2016 | https://conductscience.org/library/papers/26846681 | PubMed |
| 5 | 28298621 | Silencing nc886, a Non-Coding RNA, Induces Apoptosis of Human Endometrial Cancer Cells-1A In Vitro. | Med Sci Monit | 2017 | https://conductscience.org/library/papers/28298621 | PubMed |
| 6 | 22926522 | Cell death/proliferation roles for nc886, a non-coding RNA, in the protein kinase R pathway in cholangiocarcinoma. | Oncogene | 2013 | https://conductscience.org/library/papers/22926522 | PubMed |
| 7 | 19535462 | Efficient oligonucleotide-mediated degradation of nuclear noncoding RNAs in mammalian cultured cells. | RNA | 2009 | https://conductscience.org/library/papers/19535462 | PubMed |
| 8 | 19491402 | Evolution of vault RNAs. | Mol Biol Evol | 2009 | https://conductscience.org/library/papers/19491402 | PubMed |
| 9 | 32451752 | MicroRNAs (miRNAs) and Long Non-Coding RNAs (lncRNAs) as New Tools for Cancer Therapy: First Steps from Bench to Bedside. | Target Oncol | 2020 | https://conductscience.org/library/papers/32451752 | PubMed |
| 10 | 12861075 | The two faces of transforming growth factor beta in carcinogenesis. | Proc Natl Acad Sci U S A | 2003 | https://conductscience.org/library/papers/12861075 | PubMed |
| 11 | 37239877 | nc886, an RNA Polymerase III-Transcribed Noncoding RNA Whose Expression Is Dynamic and Regulated by Intriguing Mechanisms. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37239877 | PubMed |
| 12 | 22986343 | Characterization of the direct physical interaction of nc886, a cellular non-coding RNA, and PKR. | FEBS Lett | 2012 | https://conductscience.org/library/papers/22986343 | PubMed |
| 13 | 27338107 | Genomic and Epigenomic Alterations in Cancer. | Am J Pathol | 2016 | https://conductscience.org/library/papers/27338107 | PubMed |
| 14 | 21179442 | MiR-886-3p down regulates CXCL12 (SDF1) expression in human marrow stromal cells. | PLoS One | 2010 | https://conductscience.org/library/papers/21179442 | PubMed |
| 15 | 29563500 | nc886 is induced by TGF-β and suppresses the microRNA pathway in ovarian cancer. | Nat Commun | 2018 | https://conductscience.org/library/papers/29563500 | PubMed |
| 16 | 12529648 | Direct activation of RNA polymerase III transcription by c-Myc. | Nature | 2003 | https://conductscience.org/library/papers/12529648 | PubMed |
| 17 | 24697205 | RNase-L control of cellular mRNAs: roles in biologic functions and mechanisms of substrate targeting. | J Interferon Cytokine Res | 2014 | https://conductscience.org/library/papers/24697205 | PubMed |
| 18 | 36596869 | Long non-coding RNAs: definitions, functions, challenges and recommendations. | Nat Rev Mol Cell Biol | 2023 | https://conductscience.org/library/papers/36596869 | PubMed |
| 19 | 37746262 | Pan-cancer analysis identified OAS1 as a potential prognostic biomarker for multiple tumor types. | Front Oncol | 2023 | https://conductscience.org/library/papers/37746262 | PubMed |
| 20 | 4332311 | A new human cell line (FaDu) from a hypopharyngeal carcinoma. | Cancer | 1972 | https://conductscience.org/library/papers/4332311 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41987897 | nc886 noncoding RNA regulates hepatitis B virus replication via PKR-dependent eIF2α phosphorylation. | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/41987897 | PubMed |
| 41963921 | Author's Response to the Commentary by Raitoharju E et al. on "Epigenome-wide analysis across the development span of pediatric acute lymphoblastic leukemia: backtracking to birth". | Mol Cancer | 2026 | https://conductscience.org/library/papers/41963921 | PubMed |
| 41097660 | Impact of Epigenome-Wide Methylation and Breast Cancer Recurrence in Women Tested Negative for BRCA Genes: The Breast Methylation Risk (BREMERI) Study. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/41097660 | PubMed |
| 40565315 | RNA Polymerase III-Transcribed RNAs in Health and Disease: Mechanisms, Dysfunction, and Future Directions. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40565315 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| DICER1 | 23405 | PubTator's text mining | https://conductscience.org/library/genes/23405 | NCBI Gene |
| EIF2AK2 | 5610 | PubTator's text mining | https://conductscience.org/library/genes/5610 | NCBI Gene |
| OAS1 | 4938 | PubTator's text mining | https://conductscience.org/library/genes/4938 | NCBI Gene |
| VTRNA2-1 | 100126299 | PubTator's text mining | https://conductscience.org/library/genes/100126299 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39409154
GET https://conductscience.org/api/papers/v1/39409154/references?page=2